✦ LIBER ✦

Preliminary Result of a Multicenter Phase II Study of Chemoradiation Therapy With Docetaxel for Elderly Patients With Stage II/III Esophageal Carcinoma

✍ Scribed by Kudo, S.; Tamaki, Y.; Hashimoto, J.; Kotani, N.; Kato, K.; Ito, Y.; Hokamura, N.; Katada, C.; Ishiyama　, H.; Nakamura, T.

Book ID: 122986543
Publisher: Elsevier Science
Year: 2012
Tongue: English
Weight: 54 KB
Volume: 84
Category: Article
ISSN: 0360-3016
DOI: 10.1016/j.ijrobp.2012.07.800

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase 2 Study of Neoadjuvant Chemoradiat

Phase 2 Study of Neoadjuvant Chemoradiation Therapy With Cisplatin Plus 5-Fluorouracil and Elective Nodal Irradiation for Stage II/III Esophageal Squamous Cell Carcinoma

✍ Ito, Y.; Kato, K.; Hashimoto, J.; Akimoto, T.; Katano, S.; Saito, Y.; Igaki, H. 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 54 KB

Randomized phase III study of chemoradia

Randomized phase III study of chemoradiation with or without amifostine for patients with favorable performance status inoperable stage II-III non-small cell lung cancer: Preliminary results

✍ Komaki R.; Lee J.S.; Kaplan B.; Allen P.; Kelly J.F.; Liao Z.; Stevens C.W.; Fos 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 333 KB

A phase II study of gemcitabine and doce

A phase II study of gemcitabine and docetaxel therapy in patients with advanced urothelial carcinoma

✍ Barbara J. Gitlitz; Carole Baker; Yvonne Chapman; Heather J. Allen; Linda D. Bos 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 79 KB 👁 2 views

## Abstract ## BACKGROUND The objectives of the current study were to evaluate the safety and efficacy of gemcitabine plus docetaxel in patients with unresectable (Stage T4 or ≥ N1) metastatic or locally advanced transitional cell carcinoma (TCC) of the urothelial tract. ## METHODS A total of 27

Biweekly docetaxel and gemcitabine as ne

Biweekly docetaxel and gemcitabine as neoadjuvant chemotherapy in stage II and III breast cancer patients: Preliminary results of a phase II and pharmacogenomic study

✍ Laura G Estévez; Pedro Sánchez-Rovira; Manuel Dómine; A León; Isabel Calvo; Ana 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 89 KB

Second Line Therapy with Weekly Low-dose

Second Line Therapy with Weekly Low-dose Docetaxel for Pretreated Non-Small-Cell Lung Carcinoma Patients: A Multicenter Italian Phase II Study

✍ A. Ardizzoia; M. Acquati; D. Fagnani; M. Giordano; M. Visini; A. Scanni; A. Quat 📂 Article 📅 2004 🏛 Springer 🌐 English ⚖ 101 KB

Combination therapy with docetaxel and l

Combination therapy with docetaxel and low dose of cisplatin in elderly patients with advanced non-small cell lung cancer: multicenter phase II study

✍ Jaime Feliu; Jose Luis Firvida; Javier Castro; Catherina Madroñal; Angeles Rodrí 📂 Article 📅 2008 🏛 Springer 🌐 English ⚖ 280 KB